Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Holding AU:RCE?
Track your performance easily

Recce Pharmaceuticals Ltd. (RCE) Share Price & Analysis

8 Followers

RCE Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.13%99.87%
― Other Institutional Investors
99.87% Public Companies and
Individual Investors

RCE FAQ

What was Recce Pharmaceuticals Ltd.’s price range in the past 12 months?
Recce Pharmaceuticals Ltd. lowest share price was AU$0.41 and its highest was AU$0.69 in the past 12 months.
    What is Recce Pharmaceuticals Ltd.’s market cap?
    Currently, no data Available
    When is Recce Pharmaceuticals Ltd.’s upcoming earnings report date?
    Recce Pharmaceuticals Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 108 days.
      How were Recce Pharmaceuticals Ltd.’s earnings last quarter?
      Recce Pharmaceuticals Ltd. released its earnings results on Aug 30, 2024. The company reported -AU$0.058 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.058.
        Is Recce Pharmaceuticals Ltd. overvalued?
        According to Wall Street analysts Recce Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Recce Pharmaceuticals Ltd. pay dividends?
          Recce Pharmaceuticals Ltd. does not currently pay dividends.
          What is Recce Pharmaceuticals Ltd.’s EPS estimate?
          Recce Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Recce Pharmaceuticals Ltd. have?
          Recce Pharmaceuticals Ltd. has 231,871,610 shares outstanding.
            What happened to Recce Pharmaceuticals Ltd.’s price movement after its last earnings report?
            Recce Pharmaceuticals Ltd. reported an EPS of -AU$0.058 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.167%.
              Which hedge fund is a major shareholder of Recce Pharmaceuticals Ltd.?
              Currently, no hedge funds are holding shares in AU:RCE
              ---

              Recce Pharmaceuticals Ltd. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Recce Pharmaceuticals Ltd.

              Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. It operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat the diseases caused by various bacterias namely Sepsis, Helicobacter Pylori, Escherichia coli, Pseudomonas aeruginosa, and others.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Resonance Health Ltd
              Race Oncology Ltd.
              PYC Therapeutics Limited
              Vita Life Sciences Limited
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis